Literature DB >> 18428074

Serum cortisol secretion during heroin abstinence is elevated only nocturnally.

Su-xia Li1, Jing Li, David H Epstein, Xiang Yang Zhang, Thomas R Kosten, Lin Lu.   

Abstract

Several studies indicate abnormalities in the hypothalamic-pituitary-adrenal axis (HPA) during acute opiate withdrawal, but protracted withdrawal has gotten less study. The current study further characterized the 24-hour time course of plasma cortisol levels in heroin-dependent individuals who were abstinent for 10-15 days, which is beyond the 5 days of acute withdrawal, compared to demographically matched healthy controls using samples collected every 3 hours over 24 hours and assessed with radioimmunoassay (RIA). The abstinent heroin-dependent participants had significantly higher plasma cortisol levels nocturnally suggesting a loss of diurnal variation in these heroin subjects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18428074      PMCID: PMC3686295          DOI: 10.1080/00952990802013664

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  25 in total

1.  Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states.

Authors:  Rajita Sinha; Makram Talih; Robert Malison; Ned Cooney; George M Anderson; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

2.  Cortisol levels and depression in men and women using heroin and cocaine.

Authors:  Amy B Wisniewski; Todd T Brown; Majnu John; Joseph Cofranceso; Elizabeth T Golub; Erin P Ricketts; Gary Wand; Adrian S Dobs
Journal:  Psychoneuroendocrinology       Date:  2005-09-12       Impact factor: 4.905

3.  'Normal' cigarette smoking increases free cortisol in habitual smokers.

Authors:  C Kirschbaum; S Wüst; C J Strasburger
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

4.  FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.

Authors:  B Allolio; U Deuss; D Kaulen; U Leonhardt; D Kallabis; E Hamel; W Winkelmann
Journal:  J Clin Endocrinol Metab       Date:  1986-12       Impact factor: 5.958

5.  Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts.

Authors:  T R Kosten; M J Kreek; J Ragunath; H D Kleber
Journal:  Biol Psychiatry       Date:  1986-02       Impact factor: 13.382

6.  The effect of cigarette smoking on adrenal cortical hormones.

Authors:  J A Baron; R J Comi; V Cryns; T Brinck-Johnsen; N G Mercer
Journal:  J Pharmacol Exp Ther       Date:  1995-01       Impact factor: 4.030

7.  Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone.

Authors:  B Allolio; H M Schulte; U Deuss; D Kallabis; E Hamel; W Winkelman
Journal:  Acta Endocrinol (Copenh)       Date:  1987-04

8.  Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects.

Authors:  R S Rittmaster; G B Cutler; D O Sobel; D S Goldstein; M C Koppelman; D L Loriaux; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1985-05       Impact factor: 5.958

9.  Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study.

Authors:  Rajita Sinha; Cheryl Lacadie; Pawel Skudlarski; Robert K Fulbright; Bruce J Rounsaville; Thomas R Kosten; Bruce E Wexler
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

10.  Salivary cortisol during opiate dependence and withdrawal.

Authors:  J. Bearn; N. Buntwal; A. Papadopoulos; S. Checkley
Journal:  Addict Biol       Date:  2001-04       Impact factor: 4.280

View more
  9 in total

1.  Inhibitory transmission in the bed nucleus of the stria terminalis in male and female mice following morphine withdrawal.

Authors:  Brennon R Luster; Elizabeth S Cogan; Karl T Schmidt; Dipanwita Pati; Melanie M Pina; Kedar Dange; Zoé A McElligott
Journal:  Addict Biol       Date:  2019-04-09       Impact factor: 4.280

2.  Elevated plasma prolactin in abstinent methamphetamine-dependent subjects.

Authors:  Todd Zorick; Mark A Mandelkern; Buyean Lee; Ma-Li Wong; Karen Miotto; Jon Shabazian; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2010-12-10       Impact factor: 3.829

3.  Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine.

Authors:  Celia Goeldner; Pierre-Eric Lutz; Emmanuel Darcq; Thomas Halter; Daniel Clesse; Abdel-Mouttalib Ouagazzal; Brigitte L Kieffer
Journal:  Biol Psychiatry       Date:  2010-10-14       Impact factor: 13.382

4.  HPA axis dysfunction during morphine withdrawal in offspring of female rats exposed to opioids preconception.

Authors:  Fair M Vassoler; Sara B Isgate; Kerri E Budge; Elizabeth M Byrnes
Journal:  Neurosci Lett       Date:  2022-01-24       Impact factor: 3.046

5.  Sex differences in hormonal responses to stress and smoking relapse: a prospective examination.

Authors:  Mustafa al'Absi; Motohiro Nakajima; Sharon Allen; Andrine Lemieux; Dorothy Hatsukami
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

Review 6.  Behavioral predictors of individual differences in opioid addiction vulnerability as measured using i.v. self-administration in rats.

Authors:  Yayi Swain; Jonathan C Gewirtz; Andrew C Harris
Journal:  Drug Alcohol Depend       Date:  2021-01-29       Impact factor: 4.492

7.  Mitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafish.

Authors:  Beng-Siang Khor; Mohd Fadzly Amar Jamil; Mohamad Ilham Adenan; Alexander Chong Shu-Chien
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

8.  Stress reveals a specific behavioral phenotype for opioid abuse susceptibility.

Authors:  Chris O'Brien; Roshni Vemireddy; Uzma Mohammed; David J Barker
Journal:  J Exp Anal Behav       Date:  2022-02-04       Impact factor: 2.215

Review 9.  Toward the Identification of a Specific Psychopathology of Substance Use Disorders.

Authors:  Angelo G I Maremmani; Pier Paolo Pani; Luca Rovai; Silvia Bacciardi; Icro Maremmani
Journal:  Front Psychiatry       Date:  2017-04-27       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.